•
Mar 31, 2017

ResMed Q3 2017 Earnings Report

Total Revenue
$514M
Previous year: $454M
+13.3%
EPS
$0.71
Previous year: $0.68
+4.4%
Gross Profit
$300M
Previous year: $260M
+15.3%
Cash and Equivalents
$827M
Previous year: $718M
+15.1%
Free Cash Flow
$53M
Total Assets
$3.42B
Previous year: $2.44B
+40.0%

ResMed

ResMed